Hong Kong Retail Distributors Stock News

SEHK:1359
SEHK:1359Capital Markets

A Look At China Cinda Asset Management (SEHK:1359) Valuation After 2025 Results And Proposed Cash Dividend

China Cinda Asset Management (SEHK:1359) has drawn fresh attention after reporting full year 2025 results that showed higher net income and earnings per share, along with a proposed 2025 cash dividend, both announced on March 31, 2026. See our latest analysis for China Cinda Asset Management. The latest full year results and proposed dividend have landed after a weak stretch for the share price. The 90 day share price return shows a 15.56% decline and the year to date share price return shows...
SEHK:1117
SEHK:1117Food

Assessing China Modern Dairy (SEHK:1117) Valuation After Earnings Board Changes And New Perpetual Notes

Earnings, board changes and new debt shape the latest picture for China Modern Dairy China Modern Dairy Holdings (SEHK:1117) just released full year 2025 results alongside board changes and a CNY 500 million 2.5% perpetual note issue, giving investors several moving parts to assess at once. See our latest analysis for China Modern Dairy Holdings. The share price has reacted to these updates, with a 1-day share price return of 4.96% and a 7-day share price return of 7.25%, while the 90-day...
SEHK:6862
SEHK:6862Hospitality

A Look At Haidilao International Holding’s Valuation After Recent Share Price Moves

Recent share performance and business snapshot Haidilao International Holding (SEHK:6862) has seen mixed share performance, with a gain over the past week but a decline over the month. Returns over the past year and past 3 months remain negative. Against that backdrop, the company reports HK$43,225.355m in revenue and net income of HK$4,049.824m, with annual revenue growth of 6.51% and net income growth of 9.54%, mainly driven by its restaurant operations in Mainland China. See our latest...
SEHK:1475
SEHK:1475Food

Asian Undervalued Small Caps With Insider Activity In April 2026

In April 2026, Asian markets are navigating a complex landscape shaped by geopolitical tensions in the Middle East and fluctuating energy prices, impacting investor sentiment and economic indicators across the region. Despite these challenges, small-cap stocks have shown resilience, with some experiencing notable insider activity that could indicate potential value opportunities. Identifying promising small-cap stocks often involves assessing their ability to withstand market volatility while...
SEHK:1440
SEHK:1440Luxury

A Look At Star Shine Holdings Group’s Valuation After Widening Losses And Lower Sales In Full Year 2025

Earnings event puts Star Shine Holdings Group in focus Star Shine Holdings Group (SEHK:1440) is drawing attention after reporting full year 2025 results, with sales of CNY 513.79 million and a net loss of CNY 98.29 million from continuing operations. Compared with the prior year, sales were CNY 584.54 million, while net loss stood at CNY 12.75 million. Basic and diluted loss per share from continuing operations were CNY 0.078, higher than CNY 0.0101 a year earlier. See our latest analysis for...
SEHK:4
SEHK:4Real Estate

Assessing Wharf (Holdings) (SEHK:4) Valuation As Ex Dividend Date Nears And Institutional Inflows Build

Wharf (Holdings) (SEHK:4) is back in focus as it trades around its upcoming ex-dividend date on April 2, 2026. Recent institutional inflows and mixed technical signals are shaping short term sentiment. See our latest analysis for Wharf (Holdings). Recent trading has been choppy, with a 1 day share price return of 1.27% and a 7 day gain of 2.38%, set against a 30 day share price return showing a 10.62% decline. At the same time, the 1 year total shareholder return of 22.65% and 3 year total...
SEHK:100
SEHK:100Software

A Look At MiniMax Group (SEHK:100) Valuation After Strong Year To Date Share Price Gains

MiniMax Group (SEHK:100) has drawn attention after recent trading swings, with a 10.4% decline over the past day alongside strong year to date and monthly gains, prompting fresh questions about how investors value this AI platform stock. See our latest analysis for MiniMax Group. That sharp 10.4% one day share price return sits against a year to date share price return of 175.22% and a 30 day share price return of 17.88%, which may suggest that recent momentum is cooling after a strong...
SEHK:1907
SEHK:1907Chemicals

China Risun Group SEHK 1907 Valuation Review After Earnings And Dividend Proposal

Why China Risun Group’s latest earnings and dividend matter for shareholders China Risun Group (SEHK:1907) has drawn fresh attention after reporting full year 2025 results showing lower sales but higher net income, alongside a proposed final dividend for shareholders. The company reported 2025 sales of CNY 39,286.48 million, compared with CNY 47,542.74 million a year earlier. Net income was CNY 58.01 million versus CNY 20.13 million. Basic and diluted earnings per share from continuing...
SEHK:3899
SEHK:3899Machinery

A Look At CIMC Enric Holdings (SEHK:3899) Valuation After Its 2025 Results And Dividend Announcement

Earnings and dividend update CIMC Enric Holdings (SEHK:3899) released full year 2025 results with sales of CN¥26,325.94 million and net income of CN¥1,135.21 million, alongside an annual dividend of HK$0.3100 per share. The company also reported basic earnings per share from continuing operations of CN¥0.561 and diluted earnings per share of CN¥0.555, figures that help you gauge how profits relate to each share owned. For income focused investors, the announced dividend is payable on June 29,...
SEHK:467
SEHK:467Oil and Gas

Assessing United Energy Group’s Valuation After 2025 Earnings Drop And Final Dividend Cancellation

Why United Energy Group’s latest results matter for shareholders United Energy Group (SEHK:467) just released its full year 2025 earnings, reporting sales of HK$19,191.27 million, lower net income compared with the previous year, and no recommended final dividend following a payout in the prior year. See our latest analysis for United Energy Group. United Energy Group’s share price has been volatile around the HK$0.55 level, with a 30 day share price return of a 32.93% decline contrasting...
SEHK:6618
SEHK:6618Consumer Retailing

How JD Health’s CF PharmTech Alliance and Equity Awards Strategy Will Impact JD Health (SEHK:6618) Investors

On March 20, 2026, CF PharmTech, Inc. announced a cooperation under which JD Health International will be the exclusive online launch platform for several major new respiratory and rhinology products over the next three years, while also exploring internet-based chronic disease management models together. Alongside this, JD Health’s recent grant of 834,412 new share awards with strict clawback terms and its deeper role in digital drug commercialization highlight how the company is tying...
SEHK:696
SEHK:696Hospitality

Did Higher 2025 EPS and Dividend Amid Softer Revenue Just Shift TravelSky's (SEHK:696) Investment Narrative?

TravelSky Technology reported its full-year 2025 results in March 2026, with revenue of CNY 8,765.84 million and net income of CNY 2,341.56 million, alongside a proposed final cash dividend of CNY 0.276 per share, subject to shareholder approval at a future AGM. An interesting angle is that net income and earnings per share increased even as revenue edged down slightly, suggesting changes in cost control or business mix may have influenced profitability. Next, we will examine how the...
SEHK:636
SEHK:636Logistics

A Look At KLN Logistics Group (SEHK:636) Valuation After 2025 Results Dividend And Board Changes

KLN Logistics Group (SEHK:636) released full year 2025 results, proposed a HK$0.16 per share final dividend, and outlined boardroom changes that reshuffle key executive and committee roles. See our latest analysis for KLN Logistics Group. At a share price of HK$6.64, KLN Logistics Group has seen a 1-year total shareholder return of 3.01%. However, its 3-year and 5-year total shareholder returns of 33.77% and 49.03% declines suggest longer term momentum has faded despite recent dividend and...
SEHK:6990
SEHK:6990Biotechs

A Look At Kelun-Biotech’s Valuation As SKB103 Gains China Regulatory Green Light

Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) just received clearance from China’s drug regulator to begin clinical development of SKB103, its first TAA PD L1 bispecific antibody drug conjugate for advanced solid tumors. See our latest analysis for Sichuan Kelun-Biotech Biopharmaceutical. The SKB103 news arrives after a strong run in the shares, with a 30 day share price return of 30.37% and a year to date share price return of 25.69%. The 1 year total shareholder return of 108.06%...